微泰醫療－Ｂ (2235.HK)

4.050 +0.050 (+1.25%) 收市：03:37PM HKT

微泰醫療－Ｂ

No. 108 Liuze Street
Cangqian Street Yuhang District
Hangzhou
China

https://www.microtechmd.com

版塊: Healthcare
行業: Medical Devices
全職員工: 760

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. Pan Zheng	Executive Chairman & CEO	1.15M	無	1971
Ms. Xiu Liu	Executive Director, Financial Controller & Secretary of the Board	806.5k	無	1980
Dr. Fei Yu	Executive Director and Director of R&D Department	1.07M	無	1982
Dr. Yonghui Shi	SVP, Chief Strategy & Development Officer, Joint Company Secretary and Executive Director	1.32M	無	1981
Ms. Fangling Xu	VP & Head of Administration Department	99.46k	無	1984
Mr. Duo Bo	Legal Officer	無	無	1992
Mr. Yi Lan	Vice President of Marketing	無	無	1971
Ms. Pik Man Chu	Joint Company Secretary	無	無	1997

截止 2022年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables in the People's Republic of China and internationally. The company's products include Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, blood glucose monitoring systems, and closed-loop artificial pancreas. It is also involved in engineering and technology research experimentation and development activities. The company was incorporated in 2011 and is headquartered in Hangzhou, the People's Republic of China.

公司管治

截至 無 止，微泰醫療－Ｂ 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。